The studies on the effect of OCPs on inflammatory, coagulation and metabolic parameters in PCOS are less robust. PCOS women always carriers the increased lifetime risk of these events. On the other hand, OCP use is associated with various venous thromboembolic and proinflammatory events in the general population. Oral contraceptive pills (OCPs) constitute the mainstay of pharmacologic therapy for women with PCOS to regularize cyclicity and ameliorate androgen excess. Low-grade chronic inflammation demonstrated by persistent moderately elevated serum levels of inflammatory and coagulatory markers plays a critical role in the pathogenesis of PCOS. Metabolic abnormalities such as obesity, insulin resistance, glucose intolerance and cardiovascular problems constitute an essential part of PCOS, all of which can have significant long-term health consequences.
Polycystic ovary syndrome (PCOS) presents clinical symptoms of menstrual abnormalities, excessive hair growth (hirsutism), scalp hair loss, acne and infertility.
0 kommentar(er)
